0001127602-14-015512.txt : 20140429
0001127602-14-015512.hdr.sgml : 20140429
20140429175927
ACCESSION NUMBER: 0001127602-14-015512
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140425
FILED AS OF DATE: 20140429
DATE AS OF CHANGE: 20140429
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Piacquad David
CENTRAL INDEX KEY: 0001602343
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-12477
FILM NUMBER: 14795293
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320-1799
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2014-04-25
0000318154
AMGEN INC
AMGN
0001602343
Piacquad David
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320-1799
1
SVP, Business Development
Common Stock
2014-04-25
4
F
0
320
113.72
D
26707
D
Common Stock
2014-04-25
4
A
0
1166
0
A
27873
D
Common Stock
2014-04-27
4
F
0
259
111.41
D
27614
D
Common Stock
2014-04-27
4
F
0
10
111.41
D
27604
D
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 4/25/2016, 4/25/2017 and 4/25/2018.
These shares include the following RSUs granted under the Company's equity plans: 3,750 RSUs which fully vest on 8/3/2014; 632 RSUs which fully vest on 4/25/2015; 1,005 RSUs which vest in 2 annual installments of 495 on 4/27/2015 and 510 on 4/27/2016; 840 RSUs which vest in 2 equal installments of 277 each on 4/26/2015 and 4/26/2016 and one installment of 286 on 4/26/2017; and 9,226 RSUs which vest in 2 equal installments of 4,163 each on 4/26/2015 and 4/26/2017. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 221 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional amount.
/s/ David A. Piacquad
2014-04-29